Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Julphar
Harvard Business School
UBS
McKinsey
Accenture
Cerilliant
QuintilesIMS

Generated: April 25, 2018

DrugPatentWatch Database Preview

CYTOSAR-U Drug Profile

« Back to Dashboard

When do Cytosar-u patents expire, and what generic alternatives are available?

Cytosar-u is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in CYTOSAR-U is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Drug patent expirations by year for CYTOSAR-U
Medical Subject Heading (MeSH) Categories for CYTOSAR-U
Synonyms for CYTOSAR-U
(beta-D-Arabinofuranosyl)cytosine
(non-labelled)Cytarabine-13C-15N2
04079A1RDZ
1-.beta.-D-arabinofuranosyl-cytosine
1-(arabinofuranosyl)cytosine
1-(b-D-Arabinofuranosyl)cytosine
1-Arabinofuranosylcytosine
1-beta -D-Arabinofaranosylcytosine
1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1-beta -d-arabinofuranosylcytosine
1-beta-arabinofuranosylcytosine
1-beta-D-Arabinofaranosylcytosine
1-beta-D-arabinofuranosyl cytosine
1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1-beta-D-arabinofuranosyl-cytosine
1-beta-D-Arabinofuranosylcytosine
1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside
1-beta-D-Arabinosyl-Cytosine
1-beta-D-Arabinosylcytosine
10163-EP2272828A1
10163-EP2284920A1
10163-EP2287165A2
10163-EP2287166A2
10163-EP2292603A1
10163-EP2292620A2
10163-EP2298764A1
10163-EP2298765A1
10163-EP2298774A1
10163-EP2299509A1
10163-EP2301921A1
10163-EP2301926A1
10163-EP2301936A1
10163-EP2308843A1
10163-EP2314558A1
10163-EP2316452A1
10163-EP2371810A1
10163-EP2372804A1
10163-EP2378585A1
147-94-4
147C944
15153-EP2270018A1
15153-EP2272832A1
15153-EP2275420A1
15153-EP2277565A2
15153-EP2277566A2
15153-EP2277567A1
15153-EP2277568A2
15153-EP2277569A2
15153-EP2277570A2
15153-EP2277865A1
15153-EP2292280A1
15153-EP2295055A2
15153-EP2295416A2
15153-EP2295426A1
15153-EP2295427A1
15153-EP2298748A2
15153-EP2298764A1
15153-EP2298765A1
15153-EP2298768A1
15153-EP2298778A1
15153-EP2298780A1
15153-EP2301928A1
15153-EP2305642A2
15153-EP2305689A1
15153-EP2308833A2
15153-EP2308855A1
15153-EP2308861A1
15153-EP2311453A1
15153-EP2311808A1
15153-EP2311825A1
15153-EP2311829A1
15153-EP2311840A1
15153-EP2311842A2
15153-EP2314590A1
15153-EP2316832A1
15153-EP2316833A1
15187-EP2270008A1
15187-EP2280012A2
15187-EP2281815A1
15187-EP2292233A2
15187-EP2292615A1
15187-EP2292617A1
15187-EP2301928A1
15187-EP2301933A1
15187-EP2305640A2
15187-EP2305671A1
15187-EP2308833A2
15187-EP2311827A1
15187-EP2311840A1
15187-EP2316832A1
15187-EP2316833A1
1beta -Arabinofuranasylcytosine
1beta -D-Arabinofuranosylcytosine
1beta -D-Arabinosylcytosine
1beta-Arabinofuranasylcytosine
1beta-D-Arabinofuranosylcytosine
1beta-D-Arabinosylcytosine
2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl
2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl-
2(1H)-Pyrimidinone, 4-amino-1-|A-D-arabinofuranosyl-
2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl-
2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS]
2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS]
2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl-
4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine
4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one
69-74-9 (hydrochloride)
AB0005212
AC-1075
AC1L1M4F
AC1Q52OJ
AI3-52329
AJ-45634
AK-54744
AKOS007930145
AKOS015896896
Alexan
AM84428
ANW-58969
AR3
Ara-C
Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine
Ara-Cytidine
Arabinocytidine
arabinocytosine
Arabinofuranosylcytosine
Arabinoside C
Arabinosyl Cytosine
Arabinosylcytosine
Arabitin
AraC
Aracytidine
Aracytin
Aracytine
Arafcyt
AX8008499
BDBM50087289
beta -arabinosylcytosine
beta -cytosine arabinoside
beta -D-arabinosylcytosine
beta-Ara C
beta-Arabinosylcytosine
Beta-cytosine arabinoside
beta-D-Arabinosylcytosine
BIDD:GT0371
BIDD:PXR0139
BRD-K33106058-001-07-7
BRD-K33106058-003-20-6
BTB15125
C-55053
C02961
C9H13N3O5
CAS-147-94-4
CCG-51297
CCRIS 913
CHEBI:28680
CHEMBL803
CHX 3311
Citarabina
Citarabina [INN-Spanish]
CPD000449317
CS-2177
CTK8B7927
Cyclocide
Cytarabin
Cytarabina
cytarabine
Cytarabine (JP15/USP/INN)
Cytarabine (JP17/USP/INN)
CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9)
Cytarabine [USAN:INN:BAN:JAN]
Cytarabine [USAN:USP:INN:BAN:JAN]
cytarabine liposome
cytarabine liposome injection
Cytarabine, European Pharmacopoeia (EP) Reference Standard
Cytarabine, United States Pharmacopeia (USP) Reference Standard
Cytarabine; 2(1H)-Pyrimidinone,4-amino-1-a-Darabinofuranosyl-
Cytarabinoside
Cytarabinum
Cytarabinum [INN-Latin]
Cytarbel
Cytartbine
Cytonal
Cytosar
Cytosar-U (TN)
Cytosine 1-beta-D-arabinofuranoside
Cytosine arabinofuranoside
Cytosine arabinose
Cytosine arabinoside
Cytosine arabinoside (VAN)
Cytosine beta-D-arabinofuranoside
Cytosine beta-D-arabinofuranoside hydrochloride
Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC)
Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90%
Cytosine beta-D-arabinoside
Cytosine-1-beta-D-arabinofuranoside
Cytosine-beta -arabinoside
Cytosine-beta -D-arabinofuranoside
Cytosine-beta-arabinoside
Cytosine-beta-D-arabinofuranoside
Cytosine, 1-beta -D-arabinofuranosyl-
Cytosine, 1-beta -D-arabinosyl-
Cytosine, 1-beta-D-arabinofuranosyl-
Cytosine, 1-beta-D-arabinosyl-
Cytosine, beta -D-arabinoside
Cytosine, beta-D-arabinoside
Cytosinearabinoside
D00168
D07XSN
DB00987
Depocyt
Depocyt (liposomal)
Depocyt (TN)
DepoCyte
DSSTox_CID_2877
DSSTox_GSID_22877
DSSTox_RID_76771
DTXSID3022877
EBD145460
EINECS 205-705-9
Erpalfa
FT-0082880
FT-0624314
GP6403
GTPL4827
HE003564
HMS2051K19
HMS2090A18
HMS2230M16
HSDB 3049
HY-13605
Intrathecal (injected into the spinal fluid) DepoCyt
Intrathecal cytarabine (also known as ara-C)
Iretin
J-520199
J-700005
J-700166
J10463
K-4708
KB-09511
KS-0000022L
KS-5063
KSC917S2P
Lopac0_000316
LS-860
MCULE-3945147956
MFCD00066487
MK 8242
MLS000758310
MLS001066340
MLS001424023
MolPort-001-792-509
NC00070
NCGC00093356-03
NCGC00093356-04
NCGC00093356-05
NCGC00093356-06
NCGC00142483-02
NCGC00255381-01
NCI-C04728
NSC 287459
NSC287459
NU006827
PubChem14152
PYR287
RL01868
s1648
SAM001247012
SCHEMBL3140
SL-000002
SMR000449317
Spongocytidine
SR-01000075773-3
SRI-10828_24
SRI-10828-19
SRI-10828-20
ST24043183
SY004943
Tarabine
TL8001048
Tox21_111203
Tox21_301971
TR-008148
U 19920A
U-19,920
U-19920
Udicil
UHDGCWIWMRVCDJ-CCXZUQQUSA-N
UNII-04079A1RDZ
Z1522566619
ZINC3795098

US Patents and Regulatory Information for CYTOSAR-U

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa CYTOSAR-U cytarabine INJECTABLE;INJECTION 075206-004 Dec 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa CYTOSAR-U cytarabine INJECTABLE;INJECTION 075206-002 Dec 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa CYTOSAR-U cytarabine INJECTABLE;INJECTION 075206-003 Dec 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa CYTOSAR-U cytarabine INJECTABLE;INJECTION 075206-001 Dec 30, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Deloitte
AstraZeneca
Farmers Insurance
Cerilliant
Harvard Business School
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.